Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis

World Journal of Gastroenterology

Volumn 18, Issue 36, 2012, Pages 5135-5137

  Seven, Gulseren ^a   Assaad, Adel ^a   Biehl, Thomas ^a   Kozarek, Richard A ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Biologic therapy; Infliximab; Tumor necrosis factor alpha; Ulcerative jejunoileitis

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL PAIN; ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG DOSE INCREASE; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; LAPAROTOMY; MALE; TREATMENT RESPONSE; ULCER; ULCERATIVE JEJUNOILEITIS; WEIGHT REDUCTION;

EID: 84867800056     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i36.5135     Document Type: Article

References (10)

1. Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scand J Gastroenterol 2000; 35: 785-790
2. O'Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996; 10: 671-680
3. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997; 151: 493-498
4. de Bruin PC, Kummer JA, van der Valk P, van Heerde P, Kluin PM, Willemze R, Ossenkoppele GJ, Radaszkiewicz T, Meijer CJ. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 1994; 84: 3785-3791
5. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159: 6276-6282
6. Przemioslo RT, Kontakou M, Nobili V, Ciclitira PJ. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut 1994; 35: 1398-1403
7. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-135
8. Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, Jackson R, Ghosh S. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002; 122: 800-805
9. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 2005; 17: 667-669
10. Gaia S, Bruno M, Marzano A, Novero D, Astegiano M, Actis GC, Rizzetto M. A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies. Panminerva Med 2005; 47: 269-272